Clinical trial NCT03316469 - References

Polycystic Ovary Syndrome — Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS

Citation(s)

•   Azziz R
  Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006 Mar;91(3):781-5. Epub 2006 Jan 17.
•   Balen A
  Ovulation induction. Obstet Gynaecol Reprod Med. 2004;14:261-268.
•   Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D
  Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Nov;92(11):4138-43. Epub 2007 Aug 14.
•   Dumesic DA, Lesnick TG, Stassart JP, Ball GD, Wong A, Abbott DH
  Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer. Fertil Steril. 2009 Jul;92(1):217-21. doi: 10.1016/j.fertnstert.2008.04.047.
•   Eijkemans MJ, Imani B, Mulders AG, Habbema JD, Fauser BC
  High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod. 2003 Nov;18(11):2357-62.
•   Ghobadi C, Nguyen TH, Lennard MS, Amer S, Rostami-Hodjegan A, Ledger WL
  Evaluation of an existing nomogram for predicting the response to clomiphene citrate. Fertil Steril. 2007 Mar;87(3):597-602. Epub 2006 Dec 6.
•   Hart R, Norman R
  Polycystic ovarian syndrome--prognosis and outcomes. Best Pract Res Clin Obstet Gynaecol. 2006 Oct;20(5):751-78. Epub 2006 Jun 12. Review.
•   Hintze, J
  (2011). PASS 11. NCSS, LLC. Kaysville, Utah, USA.
•   Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC
  Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab. 1998 Jul;83(7):2361-5.
•   Kurabayashi T, Suzuki M, Fujita K, Murakawa H, Hasegawa I, Tanaka K
  Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2006 Jun 1;126(2):201-5. Epub 2005 Dec 7.
•   Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC
  Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004 Jan;89(1):318-23.
•   Mashiach R, Amit A, Hasson J, Amzalzg S, Almog B, Ben-Yosef D, Lessing JB, Limor R, Azem F
  Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome. Fertil Steril. 2010 May 1;93(7):2299-302. doi: 10.1016/j.fertnstert.2009.01.125. Epub 2009 Mar 3.
•   Messinis IE
  Ovulation induction: a mini review. Hum Reprod. 2005 Oct;20(10):2688-97. Epub 2005 Jul 8. Review.

Circulating Anti-mullerian Hormone as Predictor of Ovarian Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

Details for clinical trial NCT03316469